162 related articles for article (PubMed ID: 36192427)
1. Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma.
Gao L; Rong H
Sci Rep; 2022 Oct; 12(1):16545. PubMed ID: 36192427
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
3. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
4. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Zha Z; Zhang P; Li D; Liu G; Lu L
Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
[TBL] [Abstract][Full Text] [Related]
5. EMX2OS plays a prognosis-associated enhancer RNA role in gastric cancer.
Liu GX; Tan YZ; He GC; Zhang QL; Liu P
Medicine (Baltimore); 2021 Oct; 100(41):e27535. PubMed ID: 34731149
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
7. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
Razavi H; Katanforosh A
BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs.
Xu C; Chen Z; Pan X; Liu M; Cheng G; Li J; Mei Y
Appl Biochem Biotechnol; 2022 Dec; 194(12):6255-6269. PubMed ID: 35904674
[TBL] [Abstract][Full Text] [Related]
10. Prognostic signatures and potential pathogenesis of eRNAs-related genes in colon adenocarcinoma.
Rong H; Li Y; Hu S; Gao L; Yi T; Xie Y; Cai P; Li J; Dai X; Ye M; Liao Q
Mol Carcinog; 2022 Jan; 61(1):59-72. PubMed ID: 34622496
[TBL] [Abstract][Full Text] [Related]
11. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
12. eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer.
Zhang X; Pang P; Jiang M; Cao Q; Li H; Xu Y; Li Y; Chen X; Han J
Dis Markers; 2020; 2020():8847986. PubMed ID: 33029258
[TBL] [Abstract][Full Text] [Related]
13. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.
Luo N; Fu M; Zhang Y; Li X; Zhu W; Yang F; Chen Z; Mei Q; Peng X; Shen L; Zhang Y; Li Q; Hu G
Front Cell Dev Biol; 2022; 10():935135. PubMed ID: 35859893
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma.
Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M
Front Genet; 2022; 13():794621. PubMed ID: 36313430
[No Abstract] [Full Text] [Related]
16. Comprehensive analysis to identify DNA damage response-related lncRNA pairs as a prognostic and therapeutic biomarker in gastric cancer.
Yang Y; Zhou L; Gou X; Wu G; Zheng Y; Liu M; Chen Z; Wang Y; Ji R; Guo Q; Zhou Y
Math Biosci Eng; 2022 Jan; 19(1):595-611. PubMed ID: 34903003
[TBL] [Abstract][Full Text] [Related]
17. Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs.
Fan Z; Wang Y; Niu R
Funct Integr Genomics; 2022 Oct; 22(5):919-936. PubMed ID: 35665866
[TBL] [Abstract][Full Text] [Related]
18. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
Zong Z; Li H; Yu ZM; Tang FX; Zhu XJ; Tian HK; Zhou TC; Wang H
Gastroenterol Hepatol; 2020 Dec; 43(10):598-606. PubMed ID: 32674880
[TBL] [Abstract][Full Text] [Related]
19. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
20. Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA.
Cai Y; Wu S; Jia Y; Pan X; Li C
J Immunol Res; 2022; 2022():1249290. PubMed ID: 35528617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
